Athanasiou, A <br/><br/>
c-mos immunoreactivity is an indicator of good prognosis in lung cancer.  [electronic resource] 

 -  Histopathology  Jul 2000 
 - 45-54 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0309-0167 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2559.2000.00898.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Carcinoma, Non-Small-Cell Lung--metabolism<br/>Carcinoma, Small Cell--metabolism<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Lung Neoplasms--metabolism<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Proto-Oncogene Mas<br/>Proto-Oncogene Proteins c-mos--metabolism<br/>Survival Analysis